Meet multiple myeloma specialist Robert Orlowski, M.D., Ph.D.

(1:29)

Precursor Conditions - Robert Orlowski, MD, PhD | MCRT Houston, Texas March 26, 2022

(16:18)

The 2024 Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson

(1:15:33)

Questioning Paradigms - Robert Orlowski, MD, PhD | MCRT Houston, Texas March 26, 2022

(30:34)

Myeloma Crowd Radio/MCRI: Dr. Robert Orlowski, MD, PhD, Del 17p

(1:1:40)

Myeloma Crowd Radio: Dr. Robert Orlowski, MD, PhD, MD Anderson Cancer Center

(1:15:10)

Myeloma Crowd Radio: Dr. Robert Z. Orlowski, MD, PhD MD Anderson Cancer Center

(1:1:28)

Ep:270 ARE YOU OVER OR UNDERDOSING VITAMIN D? AND WHY IT MATTERS - by Robert Cywes

(18:42)

Multiple Myeloma: Past, Present, and Personalized | Detroit Roundtable, October 12, 2024

(26:14)

Targeting the Number One Killer, Atherosclerosis - Repair Biotechnologies | Lifespan.IO

(23:6)

Schumacher Youngsters Orlowski \u0026 Iivonen Give Us All Some Advice

(9:53)

The A.I. Dilemma - March 9, 2023

(1:7:31)

Professor Robert H. Grubbs - 2005 Nobel Laureate in Chemistry

(3:24)

Jeff Orlowski | The Social Dilemma | Talks at Google

(1:27)

PROTEOSOME INHIBITORS Mechanism of Action. Pharmacology. Bortezomib, Ixazomib. Myeloma treatment.

(7:2)

Targeting the Ubiquitin Proteasome System in Cancer: The Proteotoxic Crisis Hypothesis

(58:3)

Chopin at the Piano - The 23 Greatest Solo Piano Works | Robert Greenberg

(5:29)

The HemOnc Pulse Live at ASH: Robert Orlowski, MD, PhD, on Bispecifics, MRD in Myeloma

(11:3)

HealthTree Podcast for Multiple Myeloma: Dr. Robert Orlowski on Myeloma in 2022

(1:15:33)

Myeloma Innovations in 2023 - An Annual Review with Robert Orlowski, MD, PhD

(1:30:52)

Myeloma Crowd Radio: Robert Z. Orlowski, MD, PhD, MD Anderson Cancer Center

(1:8:9)

Myeloma Crowd Radio: Robert Orlowski, MD, PhD, MD Anderson Cancer Center

(1:3:32)

HealthTree Podcast: Robert Z. Orlowski, MD, PhD, MD Anderson Myeloma in 2021

(1:24:)

Myeloma Crowd Radio: Dr. Robert Z. Orlowski, MD, PhD, MD Anderson Cancer Center

(1:12:42)

Dr. Robert Z Orlowski on the Importance of the Phase III SWOG S0777 Trial

(2:11)

ASH 2018 - Multiple Myeloma Highlights

(9:22)

Looking to the Future of Myeloma Care

(3:2)

Optimizing proteasome inhibitors for the treatment of multiple myeloma

(5:15)

Conquer Cancer Foundation Funding Leads to New Multiple Myeloma Drug

(4:7)